• Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Consensus Recommendation of "Moderate Buy" by Analysts

    Источник: Buzz FX / 13 ноя 2024 05:16:19   America/New_York


    Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Consensus Recommendation of "Moderate Buy" by Analysts Written by MarketBeat November 13, 2024 Share Link copied to clipboard. Iovance Biotherapeutics, Inc.
    Read more...
Опубликовать